Robert M. Rifkin, MD, FACP

Robert M. Rifkin, MD, FACP is a board-certified medical oncologist and hematologist specializing in malignant and benign hematology, treating blood cancers and disorders. He has advanced subspecialty expertise in coagulation disorders, multiple myeloma, and biosimilars. Rifkin practices evidence-based medicine and follows National Comprehensive Cancer Network (NCCN) guidelines for cancer treatment. He is the medical director of Biosimilars for McKesson, associate chair of Hematology Research and Myeloma disease lead for The US Oncology Network, and oncologist and hematologist with Rocky Mountain Cancer Centers.